Navigation Links
CEM Introduces New Breakthrough Technology for Microwave Peptide Synthesis
Date:6/24/2013

MATTHEWS, N.C., June 24, 2013 /PRNewswire/ -- CEM Corporation, a leading global provider of microwave laboratory instrumentation is pleased to announce the introduction of a new family of products that significantly alters the paradigm of peptide synthesis from early discovery through pre-clinical studies. The Liberty Blue™ line of research scale microwave peptide synthesizers and the Liberty XL™ mid-scale microwave peptide synthesizer were given an enthusiastic reception by attendees of the 23rd American Peptide Symposium in Waikoloa, Hawaii on Sunday, June 23rd.

(Photo:  http://photos.prnewswire.com/prnh/20130623/CL33755)
(Logo:  http://photos.prnewswire.com/prnh/20090622/CL35336LOGO-b)

The Liberty Blue technology allows for 4-minute cycle times and a 90% reduction in solvent usage compared to existing methods for making peptides. The technology represents significant advances in hardware design, as well as remarkable improvements to the chemistry, resulting in greater speed and flexibility, better peptide purities and yields, and improved reliability.

"This is transformational technology that will dramatically change the world of peptide synthesis," said Michael J. Collins, president and CEO of CEM Corporation, "It will provide the unprecedented ability to run the gamut of peptide synthesis from generating milligram amounts for lead optimization to building targeted libraries of peptides to producing 200-gram quantities for pre-clinical studies."

"Cycle times are 10 times faster than current microwave synthesizers, allowing chemists to make a normal peptide in less than an hour. In addition, even with the fast cycle times, these new microwave peptide synthesizers produce peptides in unparalleled purities," Collins continued.

The systems' patent-pending Flex-Add™ Technology provides infinite volume delivery with a high degree of accuracy and precision, allowing the Liberty Blue line coverage of a wide scale range from 0.025 to 5 mmol, the broadest range of any line of research scale microwave peptide synthesizers. In addition, the chemistry is directly scalable up to 100 mmol with the new Liberty XL.

Designed for maximum speed, efficiency, and ease-of-use, the Liberty Blue line of microwave peptide synthesizers consists of manual, automated, and high-throughput systems, while the Liberty XL is an automated mid-scale system. The systems feature CEM's patented technology for using microwave energy for both the coupling and deprotection steps of the synthesis, ensuring higher purities and yields faster than ever before.

"We expect Liberty Blue and Liberty XL to have an even greater impact on peptide synthesis than the introduction of our original microwave peptide technology, which has become the method of choice for many researchers. These new products will give chemists the opportunity to once again push the boundaries of peptide synthesis," concluded Collins.

CEM Corporation, a private company based in Matthews, North Carolina, is the leading global company specializing in scientific solutions for critical laboratory applications. The Company has subsidiaries in the United Kingdom& Ireland, Germany, Italy, France, and Japan, as well as a global network of distributors. CEM designs and manufactures systems for bioscience applications, life sciences, analytical laboratories and processing plants worldwide. The Company's products are used in many industries including pharmaceutical, biotech, chemical, and food processing, as well as academic research.


'/>"/>
SOURCE CEM Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Flagship Biosciences Introduces a New Technique for Measuring Fibrosis in Nonalcoholic Steatohepatitis
2. Cole-Parmer Introduces Eco-Friendly Waterless Bead Baths
3. Nanounity Introduces the Pemtron Range of Compact Scanning Electron Microscopes
4. ExakTime Introduces AccountLinx Plus
5. Swiss Jewel Introduces the Crown Jewels of Fiber-Optic Connectors
6. Eagle Biosciences Introduces Highly Sensitive Calprotectin ELISA Assay Kit
7. MedeAnalytics Introduces New Provider Engagement Solution at AHIP Institute 2013
8. Alpha Technics Introduces the t-Pod™ Temperature Measurement System
9. NDA Partners Introduces New Premier Expert Consultants
10. Clinverse, Inc. Introduces ClinSpend to Meet Challenges of Sunshine Act Reporting Requirements
11. DNA2.0 Introduces Simple, IP-Free©, Scarless Cloning
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... 23, 2017 , ... BellBrook Labs is formalizing a significant ... of biochemical analyses critical for Lead Discovery. The company’s Lead Discovery Services ... including inhibitor potency and selectivity, mechanism of action, and inhibitor residence times on ...
(Date:2/23/2017)... , Feb. 23, 2017  MIODx announced today ... two key immunotherapy technologies from the University of ... a method to monitor a patient for response ... and CTLA-4.  The second license extends the technology ... is likely to have an immune-related adverse event ...
(Date:2/23/2017)...  Seattle,s upscale Capitol Hill neighborhood, with its swanky shops, parks ... head lice treatment salon to set up shop. But there,s ... a French bistro on E Madison Ave, and CEO ... old lice clinic, we pride ourselves on being a destination ... of the stigma associated with lice. Everyone can get lice ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... (FDA) de novo clearance to begin marketing the SPEAC® System, the Brain Sentinel® ... adults at home or in healthcare facilities during periods of rest. A lightweight, ...
Breaking Biology Technology:
(Date:2/8/2017)... BEDFORD, Mass., Feb. 7, 2017  Aware, Inc. (NASDAQ: ... services, today reported financial results for its quarter and year ... fourth quarter of 2016 was $3.9 million compared to $6.9 ... the fourth quarter of 2016 was $0.6 million compared to ... in the fourth quarter of 2016 was $0.5 million, or ...
(Date:2/7/2017)... , Feb. 7, 2017 Zimmer Biomet Holdings, ... musculoskeletal healthcare, will present at the LEERINK Partners 6th ... Palace Hotel on Wednesday, February 15, 2017 at 10 ... of the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh ... the conference via Zimmer Biomet,s Investor Relations website at ...
(Date:2/2/2017)...   TapImmune, Inc. (NASDAQ: ... the development of innovative peptide and gene-based immunotherapeutics ... metastatic disease, announced today it has successfully completed ... second clinical lot of TPIV 200, the company,s ... manufactured vaccine product will be used to supply ...
Breaking Biology News(10 mins):